BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Laser capture microdissection, Phenobarbital, rs7903146, TGFB1, Coagulation)
Bookmark Forward

QuickView for MYC (gene)


Body Atlas

Most Correlated Tissues

  1. B lymphocyte (IgM memory) of spleen
  2. Vena cava
  3. Granulocyte-macrophage progenitor cell of bone marrow
  4. B lymphocyte (naive) of spleen
  5. Omental adipose tissue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hyperoxia
  2. B-cell lymphoma
  3. Whipple's disease
  4. Physical activity
  5. Irritable bowel syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CEP 14083
  2. microcystin RR
  3. FGF10 protein, human
  4. Quinacrine
  5. CGP 60474
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Bcl6
  2. MIR141
  3. KAT5
  4. PRKDC
  5. MAP2K7
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MYC as a target for cancer treatment.
  2. Genetic abnormality and protein expression of C-MYC and PD-L1 in ALK-negative anaplastic large cell …
  3. Anti- c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro.
  4. Long non-coding RNAs and MYC association in hematological malignancies.
  5. Circadian regulation of c-MYC in mice.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Dose-adjusted EPOCH-R in MYC Positive DLBCL
  2. Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
  3. Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
  4. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients …
  5. BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.